Shan Zeng Selected Research

Lung Neoplasms (Lung Cancer)

1/2023	Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies ± other therapies in lung cancer: a systematic review and meta-analysis.
12/2020	[Analysis of Pulmonary Microbial Diversity in Patients with Advanced Lung Cancer Based on High-throughput Sequencing Technology].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shan Zeng Research Topics

Disease

85	Neoplasms (Cancer) 05/2024 - 03/2002
16	Rheumatoid Arthritis 03/2024 - 10/2014
14	Inflammation (Inflammations) 10/2023 - 02/2004
13	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 06/2013
12	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2023 - 03/2002
12	Neoplasm Metastasis (Metastasis) 07/2023 - 01/2012
11	Colonic Neoplasms (Colon Cancer) 02/2022 - 01/2013
9	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2007
9	Breast Neoplasms (Breast Cancer) 12/2021 - 08/2009
6	Experimental Arthritis 03/2024 - 01/2016
5	Adenocarcinoma of Lung 06/2023 - 01/2021
5	Carcinoma (Carcinomatosis) 12/2017 - 02/2005
5	Embryo Loss 10/2009 - 10/2005
4	Arthritis (Polyarthritis) 03/2024 - 01/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 12/2019
4	Brain Neoplasms (Brain Tumor) 12/2023 - 01/2020
4	Glioma (Gliomas) 02/2023 - 01/2020
4	Carcinogenesis 01/2022 - 01/2013
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 06/2013
4	Stomach Neoplasms (Stomach Cancer) 12/2017 - 11/2013
4	Ischemia 10/2012 - 02/2004
4	Reperfusion Injury 10/2012 - 02/2004
3	ST Elevation Myocardial Infarction 12/2020 - 05/2016
3	Hypertension (High Blood Pressure) 11/2019 - 01/2011
3	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 05/2014
3	Ventricular Remodeling 02/2014 - 08/2008
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2010 - 01/2008
3	Necrosis 02/2004 - 04/2002
2	Lymphoma (Lymphomas) 12/2023 - 02/2016
2	Microsatellite Instability 11/2023 - 10/2021
2	Myocardial Infarction 05/2023 - 08/2008
2	Lung Neoplasms (Lung Cancer) 01/2023 - 12/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2023
2	Bites and Stings (Sting) 03/2022 - 11/2019
2	Autoimmune Diseases (Autoimmune Disease) 02/2022 - 01/2016
2	Heart Failure 01/2022 - 05/2016
2	Stroke (Strokes) 01/2022 - 01/2011
2	Ischemic Stroke 01/2022 - 05/2016
2	Headache (Headaches) 01/2021 - 07/2002
2	Pain (Aches) 01/2021 - 02/2020
2	COVID-19 01/2021 - 01/2020
2	Wounds and Injuries (Trauma) 01/2021 - 12/2015
2	Fatigue 01/2021 - 07/2002

Drug/Important Bio-Agent (IBA)

25	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2013
16	Proteins (Proteins, Gene)FDA Link 02/2022 - 07/2007
10	Imatinib Mesylate (Gleevec)FDA Link 11/2023 - 03/2002
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 09/2015
6	Therapeutic UsesIBA 03/2024 - 10/2014
6	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2013
6	Small Interfering RNA (siRNA)IBA 11/2019 - 12/2015
5	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2017
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 08/2006
4	perillyl alcoholIBA 12/2023 - 10/2021
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2023 - 01/2018
4	LigandsIBA 01/2023 - 03/2002
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2013
4	B7-H1 AntigenIBA 01/2022 - 01/2017
4	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 09/2015
4	Phosphotransferases (Kinase)IBA 01/2020 - 03/2002
4	EnzymesIBA 01/2017 - 03/2002
3	VaccinesIBA 02/2023 - 01/2020
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2017
3	AntibodiesIBA 01/2023 - 01/2016
3	pembrolizumabIBA 01/2022 - 12/2019
3	pyrotinibIBA 01/2021 - 01/2020
3	Bone Morphogenetic Protein 4IBA 11/2020 - 01/2017
3	CytokinesIBA 01/2020 - 10/2012
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 12/2015
3	Indicators and Reagents (Reagents)IBA 01/2018 - 11/2013
3	CateninsIBA 12/2017 - 01/2017
3	Cadherins (E-Cadherin)IBA 12/2017 - 04/2016
3	Poly I-CIBA 10/2009 - 10/2005
2	JNK Mitogen-Activated Protein KinasesIBA 01/2024 - 10/2012
2	Interleukin-2 (IL2)IBA 02/2023 - 01/2020
2	Cancer VaccinesIBA 02/2023 - 01/2020
2	AntigensIBA 03/2022 - 10/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2017
2	LipidsIBA 01/2022 - 12/2020
2	Trastuzumab (Herceptin)FDA Link 12/2021 - 10/2021
2	Interferon-gamma (Interferon, gamma)IBA 10/2021 - 06/2009
2	Long Noncoding RNAIBA 09/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2016
2	Cetuximab (Erbitux)FDA Link 07/2020 - 01/2020
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2009
2	Leucovorin (Folinic Acid)FDA Link 01/2020 - 06/2018
2	regorafenibIBA 01/2020 - 01/2020
2	InterferonsIBA 01/2020 - 11/2019
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019 - 12/2017
2	Epidermal Growth Factor (EGF)IBA 09/2018 - 07/2010
2	piperlongumineIBA 03/2018 - 01/2016

Therapy/Procedure

28	Therapeutics 05/2024 - 08/2011
19	Immunotherapy 05/2024 - 08/2011
15	Drug Therapy (Chemotherapy) 01/2022 - 08/2006
3	Aftercare (After-Treatment) 02/2023 - 01/2020
3	Percutaneous Coronary Intervention 12/2020 - 05/2016
3	Radiotherapy 11/2019 - 11/2017
3	Intraperitoneal Injections 01/2017 - 08/2009
3	Liver Transplantation 02/2012 - 02/2004
2	Immunomodulation 07/2023 - 01/2016
2	Lymph Node Excision (Lymph Node Dissection) 11/2019 - 02/2017